Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.22B | $ 2.85B | $ 2.42B | $ 2.10B | $ 1.85B |
| Gross Profit | $ 2.48B | $ 2.27B | $ 1.89B | $ 1.59B | $ 1.38B |
| Operating Income | $ 533.48M | $ 484.21M | $ 185.77M | $ 160.97M | $ -82.34M |
| EBITDA | $ 572.94M | $ 650.53M | $ 306.77M | $ 265.36M | $ 47.43M |
| Net Income | $ 348.90M | $ 426.86M | $ 167.65M | $ 141.56M | $ -64.08M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.56B | $ 1.14B | $ 1.07B | $ 1.29B | $ 1.01B |
| Total Assets | $ 7.59B | $ 6.99B | $ 6.84B | $ 6.38B | $ 6.00B |
| Total Debt | $ 597.18M | $ 649.47M | $ 1.10B | $ 1.09B | $ 1.09B |
| Net Debt | $ -714.50M | $ -293.38M | $ 340.62M | $ 368.86M | $ 502.26M |
| Total Liabilities | $ 1.51B | $ 1.33B | $ 1.89B | $ 1.77B | $ 1.74B |
| Stockholders' Equity | $ 6.09B | $ 5.66B | $ 4.95B | $ 4.60B | $ 4.27B |
| Cash Flow | |||||
| Free Cash Flow | $ 724.96M | $ 475.42M | $ 62.57M | $ 54.94M | $ 185.31M |
| Operating Cash Flow | $ 827.99M | $ 572.84M | $ 159.26M | $ 175.90M | $ 304.54M |
| Investing Cash Flow | $ -414.24M | $ 136.49M | $ -111.24M | $ -20.03M | $ -366.31M |
| Financing Cash Flow | $ -42.39M | $ -526.45M | $ -18.73M | $ -18.65M | $ -48.00K |